CA2459348C - Anticorps au recepteur p2x7 non fonctionnel, diagnostic et traitement de cancers et d'autres conditions - Google Patents
Anticorps au recepteur p2x7 non fonctionnel, diagnostic et traitement de cancers et d'autres conditions Download PDFInfo
- Publication number
- CA2459348C CA2459348C CA2459348A CA2459348A CA2459348C CA 2459348 C CA2459348 C CA 2459348C CA 2459348 A CA2459348 A CA 2459348A CA 2459348 A CA2459348 A CA 2459348A CA 2459348 C CA2459348 C CA 2459348C
- Authority
- CA
- Canada
- Prior art keywords
- functional
- receptors
- antibody
- cells
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
La présente invention concerne une grande variété de maladies et de conditions, y compris les cancers. L'invention propose une sonde destinée à la détection d'une telle maladie ou condition. La sonde est capable de distinguer entre des récepteurs fonctionnels de P2X¿7? et de récepteurs non fonctionnels de P2X¿7?. La sonde peut établir cette distinction de diverse manières, dont une consiste en la détection d'une modification par rapport à la liaison de l'adénosine triphosphate (ATP) aux récepteurs. L'invention propose également un procédé permettant la détection de la maladie ou condition, utilisant la sonde. L'invention concerne en outre un traitement de la maladie ou condition, au moyen d'un anticorps, ou d'un épitope capable de générer l'anticorps, pouvant établir la distinction entre les récepteurs fonctionnels et non fonctionnels de P2X¿7?. Enfin, l'invention concerne des procédés de traitement, des compositions pharmaceutiques et l'utilisation de la sonde et de l'anticorps
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPR7431 | 2001-09-03 | ||
AUPR7430 | 2001-09-03 | ||
AUPR7431A AUPR743101A0 (en) | 2001-09-03 | 2001-09-03 | A cancer therapeutic |
AUPR7430A AUPR743001A0 (en) | 2001-09-03 | 2001-09-03 | Diagnosis and treatment of irritable bowel syndrome |
AUPCT/AU02/00061 | 2002-01-17 | ||
PCT/AU2002/000061 WO2002057306A1 (fr) | 2001-01-17 | 2002-01-17 | Anticorps du recepteur p2x7 non fonctionnel, diagnostic et traitement de cancers et autres etats pathologiques |
PCT/AU2002/001204 WO2003020762A1 (fr) | 2001-09-03 | 2002-09-03 | Anticorps au recepteur p2x7 non fonctionnel, diagnostic et traitement de cancers et d'autres conditions |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2459348A1 CA2459348A1 (fr) | 2003-03-13 |
CA2459348C true CA2459348C (fr) | 2013-06-18 |
Family
ID=41706691
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2459348A Expired - Lifetime CA2459348C (fr) | 2001-09-03 | 2002-09-03 | Anticorps au recepteur p2x7 non fonctionnel, diagnostic et traitement de cancers et d'autres conditions |
Country Status (9)
Country | Link |
---|---|
JP (1) | JP4467973B2 (fr) |
CN (2) | CN100497386C (fr) |
AU (1) | AU2002322192B2 (fr) |
CA (1) | CA2459348C (fr) |
MY (1) | MY142283A (fr) |
NZ (2) | NZ549019A (fr) |
TW (1) | TWI329648B (fr) |
WO (1) | WO2003020762A1 (fr) |
ZA (1) | ZA200402630B (fr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1360203E (pt) | 2001-01-17 | 2009-04-03 | Intreat Pty Ltd | Anticorpos de receptor p2x7 não funcional para diagnóstico e tratamento de cancros e outros estados |
AU2003298003A1 (en) * | 2002-12-05 | 2004-06-30 | Kla-Tencor Technologies Corporation | Apparatus and methods for detecting overlay errors using scatterometry |
WO2004090097A2 (fr) | 2003-04-03 | 2004-10-21 | Bristol-Myers Squibb Company | Polynucleotide codant un nouveau variant d'epissage p2x7 humain appele hbmyp2x7v |
US8124730B1 (en) | 2004-04-02 | 2012-02-28 | Bristol-Myers Squibb Company | Polynucleotide encoding a novel human P2X7 splice variant, HBMYP2X7v |
US7767789B2 (en) * | 2005-06-02 | 2010-08-03 | University Hopitals of Cleveland | Truncated proteins as cancer markers |
WO2008043146A1 (fr) * | 2006-10-10 | 2008-04-17 | Biosceptre International Limited | Anticorps contre le récepteur p2x7 non fonctionnel |
AU2007306924A1 (en) * | 2006-10-10 | 2008-04-17 | Biosceptre International Limited | Hybridomas producing antibodies against non functional P2X7 receptor |
CA2737126C (fr) * | 2007-09-14 | 2018-05-01 | Biosceptre International Limited | Nouveaux epitopes p2x7 |
AU2013238152B2 (en) * | 2007-09-14 | 2015-09-24 | Biosceptre International Limited | Purinergic (P2X) receptors in extra-cellular body fluid |
US8293491B2 (en) | 2007-09-14 | 2012-10-23 | Biosceptre International Limited | Purinergic (P2X) receptors in extra-cellular body fluid |
AU2009266430B2 (en) | 2008-07-04 | 2014-08-14 | Biosceptre International Limited | Anti- P2X7 peptides and epitopes |
CN101469352B (zh) * | 2008-08-29 | 2011-12-21 | 苏州福英基因科技有限公司 | 一种早期子宫癌原位杂交检测试剂盒 |
EP2966090B1 (fr) | 2009-08-20 | 2018-10-10 | Biosceptre (Aust) Pty Ltd | Anticorps du récepteur anti p2x7 et fragments de ceux-ci |
WO2011075789A1 (fr) | 2009-12-24 | 2011-06-30 | Biosceptre International Limited | Anticorps dirigés contre des récepteurs p2x7 oligomères non fonctionnels |
CN106310245A (zh) | 2010-09-10 | 2017-01-11 | 生物权威(澳大利亚)有限责任公司 | 陪伴动物治疗 |
AU2012278921B2 (en) * | 2011-07-01 | 2016-11-10 | Biosceptre International Limited | Combination therapy |
EP2990800A1 (fr) * | 2014-08-29 | 2016-03-02 | Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol | Neprilysin comme marqueur pronostique pour l'insuffisance cardiaque |
EP3347474B1 (fr) | 2015-09-11 | 2020-11-04 | Biosceptre (UK) Limited | Récepteurs d'antigènes chimériques et leurs utilisations |
AU2017346936B2 (en) * | 2016-10-21 | 2022-10-06 | Biosceptre (Aust) Pty Ltd | Cytotoxic particles |
CN110054691B (zh) * | 2019-05-09 | 2021-09-07 | 潍坊医学院 | 一种抗人p2rx7单克隆抗体的杂交瘤细胞系 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6133434A (en) * | 1997-04-28 | 2000-10-17 | Glaxo Group Limited | Purinergic receptor |
PT1360203E (pt) * | 2001-01-17 | 2009-04-03 | Intreat Pty Ltd | Anticorpos de receptor p2x7 não funcional para diagnóstico e tratamento de cancros e outros estados |
-
2002
- 2002-09-03 NZ NZ549019A patent/NZ549019A/en not_active IP Right Cessation
- 2002-09-03 CN CNB028214331A patent/CN100497386C/zh not_active Expired - Lifetime
- 2002-09-03 CA CA2459348A patent/CA2459348C/fr not_active Expired - Lifetime
- 2002-09-03 AU AU2002322192A patent/AU2002322192B2/en not_active Expired
- 2002-09-03 WO PCT/AU2002/001204 patent/WO2003020762A1/fr active Application Filing
- 2002-09-03 JP JP2003525032A patent/JP4467973B2/ja not_active Expired - Lifetime
- 2002-09-03 CN CN2008102142942A patent/CN101445555B/zh not_active Expired - Lifetime
- 2002-09-03 TW TW091120122A patent/TWI329648B/zh not_active IP Right Cessation
- 2002-09-03 NZ NZ565994A patent/NZ565994A/en not_active IP Right Cessation
- 2002-09-04 MY MYPI20023310A patent/MY142283A/en unknown
-
2004
- 2004-04-02 ZA ZA2004/02630A patent/ZA200402630B/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2003020762A1 (fr) | 2003-03-13 |
NZ549019A (en) | 2008-05-30 |
CN100497386C (zh) | 2009-06-10 |
CA2459348A1 (fr) | 2003-03-13 |
NZ565994A (en) | 2010-02-26 |
JP2005513416A (ja) | 2005-05-12 |
CN1625565A (zh) | 2005-06-08 |
AU2002322192B2 (en) | 2008-05-01 |
MY142283A (en) | 2010-11-15 |
ZA200402630B (en) | 2005-06-29 |
JP4467973B2 (ja) | 2010-05-26 |
CN101445555B (zh) | 2013-07-03 |
TWI329648B (en) | 2010-09-01 |
CN101445555A (zh) | 2009-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10450380B2 (en) | Polypeptide immunogen for generating an antibody to non-functional P2X7 receptor | |
CA2459348C (fr) | Anticorps au recepteur p2x7 non fonctionnel, diagnostic et traitement de cancers et d'autres conditions | |
AU2002322192A1 (en) | Antibodies to non-functional P2X7receptor, diagnosis and treatment of cancers and other conditions | |
Barden et al. | Antibodies to non-functional P2X7 receptor | |
Barden et al. | Non-functional P2X 7 receptor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20220906 |